All news

Johnson & Johnson analyst target sits below current price

Alpha Vantage · Trefis · · AI-summarised by FinFlash

Johnson & Johnson has significantly outperformed the S&P 500 over the past year, yet the average analyst target of $279.41 sits about 1.0% below the $282.11 price. Ratings stand at 16 Buy, 6 Hold and 1 Sell. A three-year scenario projects a 39.8% gain on sales growth and better net margins, though historical revenue growth has trailed those assumptions.

Read original source

JNJ company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.